science
automated-news
Novartis’ experimental prostate cancer drug shows promise
President Donald Trump is trying to fast-track research into psychedelics as treatments, creating new opportunities and risks.
automated-news
A 30-year-old woman has died and two other people remain in a critical condition following a suspicious fire at a flat in Hong Kong’s affluent Mid-Levels district, with police later uncovering drug-taking apparatus in a bedroom. The Hospital Authority confirmed on Sunday that the woman, who had been
automated-news
Meteor fireball triggered loud boom across New England, NASA confirms
automated-news
The Bio-Pharma Industry and Society Listing Summary Please join the CSIS Global Health Policy Center on March 17, from 10:00am – 11:30am, for an exploration of how private bio-pharmaceutical firms can better support the critically important societal goals of improved affordability, access, quality,
automated-news
"Blue Origin’s inability to launch Blue Moon anytime soon is likely to put the company out of the running for Artemis III."
Should You Buy SpaceX Stock After the Starship V3 Megarocket Launch?
automated-news
A new book looks into the long history of people who have opposed vaccines.
With Elon Musk's SpaceX IPO ahead, retail investors are rushing into space-themed ETFs including NASA which offers direct access to the rocket company.
United Therapeutics Corporation (UTHR): Renaissance Technologies Likes This Biotech Stock